Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1996 2
1997 1
1998 8
1999 10
2000 4
2001 4
2002 2
2005 1
2006 2
2007 3
2008 2
2009 2
2010 5
2011 2
2012 3
2013 3
2014 4
2015 6
2016 13
2017 31
2018 27
2019 25
2020 16
2021 17
2022 24
2023 13
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

207 results

Results by year

Filters applied: . Clear all
Page 1
NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 3.2022.
Greenberg PL, Stone RM, Al-Kali A, Bennett JM, Borate U, Brunner AM, Chai-Ho W, Curtin P, de Castro CM, Deeg HJ, DeZern AE, Dinner S, Foucar C, Gaensler K, Garcia-Manero G, Griffiths EA, Head D, Jonas BA, Keel S, Madanat Y, Maness LJ, Mangan J, McCurdy S, McMahon C, Patel B, Reddy VV, Sallman DA, Shallis R, Shami PJ, Thota S, Varshavsky-Yanovsky AN, Westervelt P, Hollinger E, Shead DA, Hochstetler C. Greenberg PL, et al. Among authors: keel s. J Natl Compr Canc Netw. 2022 Feb;20(2):106-117. doi: 10.6004/jnccn.2022.0009. J Natl Compr Canc Netw. 2022. PMID: 35130502
Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria.
Balwani M, Sardh E, Ventura P, Peiró PA, Rees DC, Stölzel U, Bissell DM, Bonkovsky HL, Windyga J, Anderson KE, Parker C, Silver SM, Keel SB, Wang JD, Stein PE, Harper P, Vassiliou D, Wang B, Phillips J, Ivanova A, Langendonk JG, Kauppinen R, Minder E, Horie Y, Penz C, Chen J, Liu S, Ko JJ, Sweetser MT, Garg P, Vaishnaw A, Kim JB, Simon AR, Gouya L; ENVISION Investigators. Balwani M, et al. Among authors: keel sb. N Engl J Med. 2020 Jun 11;382(24):2289-2301. doi: 10.1056/NEJMoa1913147. N Engl J Med. 2020. PMID: 32521132 Clinical Trial.
RNA interference therapy in acute hepatic porphyrias.
Yasuda M, Keel S, Balwani M. Yasuda M, et al. Among authors: keel s. Blood. 2023 Nov 9;142(19):1589-1599. doi: 10.1182/blood.2022018662. Blood. 2023. PMID: 37027823 Free article.
Systematic review of clinical practice guidelines for uveitis.
Ghadiri N, Reekie IR, Gordon I, Safi S, Lingham G, Evans JR, Keel S. Ghadiri N, et al. Among authors: keel s. BMJ Open Ophthalmol. 2023 Jan;8(1):e001091. doi: 10.1136/bmjophth-2022-001091. Epub 2023 Jan 5. BMJ Open Ophthalmol. 2023. PMID: 37278434 Free PMC article. Review.
Reply.
Keel S, Foreman J, Dirani M. Keel S, et al. Ophthalmology. 2018 Feb;125(2):e14. doi: 10.1016/j.ophtha.2017.08.045. Ophthalmology. 2018. PMID: 29389413 No abstract available.
Emerging ocular biomarkers of Alzheimer disease.
van Wijngaarden P, Hadoux X, Alwan M, Keel S, Dirani M. van Wijngaarden P, et al. Among authors: keel s. Clin Exp Ophthalmol. 2017 Jan;45(1):54-61. doi: 10.1111/ceo.12872. Epub 2016 Dec 19. Clin Exp Ophthalmol. 2017. PMID: 28147442 Review.
Phase 1/2 study of sorafenib added to cladribine, high-dose cytarabine, G-CSF, and mitoxantrone in untreated AML.
Halpern AB, Rodríguez-Arbolí E, Othus M, Garcia KA, Percival MM, Cassaday RD, Oehler VG, Becker PS, Appelbaum JS, Abkowitz JL, Orozco JJ, Keel SB, Hendrie PC, Scott BL, Ghiuzeli MC, Estey EH, Walter RB. Halpern AB, et al. Among authors: keel sb. Blood Adv. 2023 Sep 12;7(17):4950-4961. doi: 10.1182/bloodadvances.2023010392. Blood Adv. 2023. PMID: 37339483 Free PMC article. Clinical Trial.
Attachment-informed mentorship.
Reitz R, Mitchell S, Keel S. Reitz R, et al. Among authors: keel s. Fam Syst Health. 2017 Dec;35(4):498-504. doi: 10.1037/fsh0000300. Fam Syst Health. 2017. PMID: 29283616
207 results